Trial Profile
Clinical Trials Insight: 700036999
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2008
Price :
$35
*
At a glance
- Drugs Tobramycin (Primary)
- Indications Pseudomonal infections; Respiratory tract infections
- Focus Therapeutic Use
- Sponsors Axentis Pharma
- 11 Sep 2008 New trial record.